Hongsheng Capital

Active

Updated: Apr 1, 2026 ·

Financial History

Total Raised

N/A

Valuation

N/A

Date	Company	Round	Lead Investor(s)	Co-Investor(s)
Aug 25, 2025	Arnatar Therapeutics	$52.0M Series A	3E Bioventures Capital, Eight Roads Ventures	Chuanhua Capital, F-Prime Capital, Gaorong Capital, New Alliance Capital, Yijing Capital

Total Raised

N/A

Valuation

N/A